Correlation Between Neurocrine Biosciences and Aurora Cannabis
Can any of the company-specific risk be diversified away by investing in both Neurocrine Biosciences and Aurora Cannabis at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neurocrine Biosciences and Aurora Cannabis into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Neurocrine Biosciences and Aurora Cannabis, you can compare the effects of market volatilities on Neurocrine Biosciences and Aurora Cannabis and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neurocrine Biosciences with a short position of Aurora Cannabis. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neurocrine Biosciences and Aurora Cannabis.
Diversification Opportunities for Neurocrine Biosciences and Aurora Cannabis
-0.63 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Neurocrine and Aurora is -0.63. Overlapping area represents the amount of risk that can be diversified away by holding Neurocrine Biosciences and Aurora Cannabis in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aurora Cannabis and Neurocrine Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neurocrine Biosciences are associated (or correlated) with Aurora Cannabis. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aurora Cannabis has no effect on the direction of Neurocrine Biosciences i.e., Neurocrine Biosciences and Aurora Cannabis go up and down completely randomly.
Pair Corralation between Neurocrine Biosciences and Aurora Cannabis
Given the investment horizon of 90 days Neurocrine Biosciences is expected to generate 0.64 times more return on investment than Aurora Cannabis. However, Neurocrine Biosciences is 1.56 times less risky than Aurora Cannabis. It trades about 0.04 of its potential returns per unit of risk. Aurora Cannabis is currently generating about -0.11 per unit of risk. If you would invest 12,551 in Neurocrine Biosciences on September 14, 2024 and sell it today you would earn a total of 128.00 from holding Neurocrine Biosciences or generate 1.02% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 95.45% |
| Values | Daily Returns |
Neurocrine Biosciences vs. Aurora Cannabis
Performance |
| Timeline |
| Neurocrine Biosciences |
| Aurora Cannabis |
Neurocrine Biosciences and Aurora Cannabis Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Neurocrine Biosciences and Aurora Cannabis
The main advantage of trading using opposite Neurocrine Biosciences and Aurora Cannabis positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neurocrine Biosciences position performs unexpectedly, Aurora Cannabis can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aurora Cannabis will offset losses from the drop in Aurora Cannabis' long position.| Neurocrine Biosciences vs. Puma Biotechnology | Neurocrine Biosciences vs. Iovance Biotherapeutics | Neurocrine Biosciences vs. Day One Biopharmaceuticals | Neurocrine Biosciences vs. Inozyme Pharma |
| Aurora Cannabis vs. Emergent Biosolutions | Aurora Cannabis vs. Bausch Health Companies | Aurora Cannabis vs. Neurocrine Biosciences | Aurora Cannabis vs. Teva Pharma Industries |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Other Complementary Tools
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |